2026: A Record Year for ACE & Company

2025 was a record year for ACE & Company.

$1.9bn in total assets.
$150m distributed.
$280m in gains.
$155m deployed across leading companies.

Across our platform, we delivered consistent execution in a changing market environment. In Secondaries, the market expanded to approximately $200bn as pricing improved and activity accelerated across buyouts, venture, and growth. We executed 15 single-fund transactions, completed 6 portfolio wind-downs, and delivered 16 distributions across 5 funds, with a continued focus on DPI. Upgraded pricing tools and AI-driven workflows increased throughput by around 30 percent.

In Buyout, broader LBO markets began to recover while the lower mid-market remained resilient. Over the past 12 months, we distributed close to $100m and achieved standout exits including Nord Anglia and PatientPoint. Through ABO V, we completed six new investments across our core sectors, supported by a strengthened data and AI-powered screening engine.

In ACE Ventures, deal volumes declined while capital invested remained stable, with a clear focus on fewer, larger AI and robotics rounds. We backed exceptional teams, leading investments in Scholé and Veezoo. Momentum has carried into 2026, with major follow-on rounds and upcoming liquidity events already underway.

Featured twice in the Financial Times and continuing to strengthen our local footprint, 2025 reflects the resilience of our team, the discipline of our investment approach, and the strength of our platform.

Focused on what comes next, we carry this momentum into 2026.